Neuropace

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuropace and other ETFs, options, and stocks.

About NPCE

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads.

CEO

Joel D. Becker

CEOJoel D. Becker

Employees

184

Employees184

Headquarters

Mountain View, California

HeadquartersMountain View, California

Founded

1997

Founded1997

Employees

184

Employees184

NPCE Key Statistics

Market cap

579.22M

Market cap579.22M

Price-Earnings ratio

-21.29

Price-Earnings ratio-21.29

Dividend yield

—

Dividend yield—

Average volume

515.15K

Average volume515.15K

High today

$18.25

High today$18.25

Low today

$16.95

Low today$16.95

Open price

$17.77

Open price$17.77

Volume

224.42K

Volume224.42K

52 Week high

$18.98

52 Week high$18.98

52 Week low

$5.45

52 Week low$5.45

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own NPCE. This list is generated using Robinhood data, and it’s not a recommendation.

Neuropace

Why Robinhood?

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. Show more

NPCE Key Statistics

Analyst ratings

100%

People also own

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads.